Trial · NCT03179631
Adverse events224
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
41 to 60 of 224
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Headache | Nervous system disorders | DB Period: Ataluren | 19 | 184 | 38 |
| other | Headache | Nervous system disorders | DB Period: Placebo | 15 | 176 | 22 |
| other | Headache | Nervous system disorders | Ataluren /Ataluren | 22 | 184 | 56 |
| other | Headache | Nervous system disorders | Ataluren/Placebo | 6 | 172 | 29 |
| other | Cough | Respiratory, thoracic and mediastinal disorders | DB Period: Ataluren | 18 | 184 | 23 |
| other | Cough | Respiratory, thoracic and mediastinal disorders | DB Period: Placebo | 20 | 176 | 32 |
| other | Cough | Respiratory, thoracic and mediastinal disorders | Ataluren /Ataluren | 25 | 184 | 35 |
| other | Cough | Respiratory, thoracic and mediastinal disorders | Ataluren/Placebo | 6 | 172 | 7 |
| other | Rhinorrhoea | Respiratory, thoracic and mediastinal disorders | DB Period: Ataluren | 12 | 184 | 16 |
| other | Rhinorrhoea | Respiratory, thoracic and mediastinal disorders | DB Period: Placebo | 5 | 176 | 9 |
| other | Rhinorrhoea | Respiratory, thoracic and mediastinal disorders | Ataluren /Ataluren | 16 | 184 | 20 |
| other | Rhinorrhoea | Respiratory, thoracic and mediastinal disorders | Ataluren/Placebo | 3 | 172 | 4 |
| other | Constipation | Gastrointestinal disorders | DB Period: Ataluren | 0 | 184 | 0 |
| other | Constipation | Gastrointestinal disorders | DB Period: Placebo | 0 | 176 | 0 |
| other | Constipation | Gastrointestinal disorders | Ataluren /Ataluren | 11 | 184 | 12 |
| other | Constipation | Gastrointestinal disorders | Ataluren/Placebo | 4 | 172 | 4 |
| other | COVID-19 | Infections and infestations | DB Period: Ataluren | 0 | 184 | 0 |
| other | COVID-19 | Infections and infestations | DB Period: Placebo | 0 | 176 | 0 |
| other | COVID-19 | Infections and infestations | Ataluren /Ataluren | 8 | 184 | 8 |
| other | COVID-19 | Infections and infestations | Ataluren/Placebo | 12 | 172 | 13 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03179631/events?page=3